Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bacteria

ABSTRACT: WGS of bacterial isolates from berries

PROVIDER: PRJNA1260214 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR33473319_1.fastq.gz	Fastqsanger.gz
	SRR33473319_2.fastq.gz	Fastqsanger.gz
	SRR33473320_1.fastq.gz	Fastqsanger.gz
	SRR33473320_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 41

Similar Datasets

bacteria

Project description:WGS of historical LFFM isolates

| PRJNA1118266 | ENA

Bacteria

Project description:Bacterial isolates from Ukrainian soldiers

| PRJNA1178460 | ENA

Bacteria

Project description:Human oral bacterial isolates Genome sequencing

| PRJNA282954 | ENA

Project description:WGS Al Wahbah bacterial isolates

| PRJNA811115 | ENA

Project description:WGS of Gut Bacterial Isolates

| PRJNA1207706 | ENA

Bacteria

Project description:A project of associating bacterial WGS and AST data

| PRJDB7087 | ENA

Bacteria

Project description:Genome sequencing and assembly of bacterial isolates

| PRJNA666993 | ENA

Bacteria

Project description:ESBL plasmid evolution in clinical bacterial isolates

| PRJNA325878 | ENA

Rifampin mediated decapsulation and enhanced bacterial clearance: a new mechanism of rifamycins

Project description:Many clinically relevant bacterial pathogens are encapsulated, as exemplified by Salmonella enterica serovar Typhi. S. Typhi, the causative agent of the life-threatening systemic disease enteric fever, expresses Vi as the outermost surface glycan that protects the bacteria from host immune responses. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) S. Typhi strains, as well as Vi variants, are widespread globally. Our WGS analyses indicate that almost all S. Typhi clinical isolates are susceptible to rifamycins and azithromycin. Rifampin, even at sub-MIC levels, eliminates the protective capsule Vi, a process referred to as ‘decapsulation’, thereby enhancing bacterial clearance. Antibiotic-mediated decapsulation of S. Typhi appears specific to rifamycins, since azithromycin does not decapsulate S. Typhi. Rifampin mediated decapsulation occurs at the transcriptional level, where both high AT content and specific RpoB residues play a crucial role. Rifampin also effectively decapsulates Vi variants, which accounts for 1 in 5 S. Typhi isolates at the global level. A mechanistic explanation for rifampin mediated decapsulation of S. Typhi appears to be applicable to other encapsulated pathogens, including S. Paratyphi C.

2025-05-15 | GSE295448 | GEO

Bacteria

Project description:Bacterial isolates with capabilities of abiotic stress tolerance

| PRJNA351914 | ENA